Supreme Court to Consider BPCIA Requirements for Biosimilars
The Supreme Court of the United States has granted certiorari in a case involving the Biologics Price Competition and Innovation Act of 2009 in the context of a biosimilars dispute. Sandoz, Inc. v.
from Biotech News
0 Comments